R
RGEN
Repligen
131.03
+8.44+6.88%After Hours: 131.03 0.00 0.00%16:04 04/14 EDT
OPEN/PREV CLOSE124.11/122.59
TODAY RANGE123.83-131.38
VOL1.22M
MARKET CAP7.39B
52 WEEK RANGE109.66-175.77
AVG VOL (3M)835.93K
% TURNOVER2.16%
TURNOVER--
P/E (TTM)151.58
% RANGE6.16%
EPS(TTM)0.8644
P/E(FORWARD)119.12
P/B3.504
BVPS37.39
DIVIDEND--
P/S10.00
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP6.96B
SHARES OUTSTANDING56.40M
NEXT EARNINGS04/27-05/01
FREE FLOAT53.10M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·9h ago
Repligen price target lowered to $145 from $175 at Barclays
Seeking Alpha·6d ago
Repligen: Advancing, Yet Much More Work Ahead
Dow Jones·04/06 18:01
Repligen Price Target Cut to $140.00/Share From $170.00 by Evercore ISI Group
Benzinga·04/06 17:51
Evercore ISI Group Maintains Outperform on Repligen, Lowers Price Target to $140
Simply Wall St·04/05 03:26
Reassessing Repligen (RGEN) Valuation After Recent Share Price Rebound And Bioprocessing Growth Expectations
Reuters·04/03 11:20
Repligen publishes 2025 annual report, posts $738 million revenue in 2025
Reuters·03/31 20:35
Q/C Technologies delays annual report filing, seeks 15-day extension
Simply Wall St·03/31 19:07
Is Repligen (RGEN) Pricing Look Attractive After Steep Multi Year Share Price Declines
Dow Jones·03/23 11:18
Repligen Price Target Raised to $208.00/Share From $180.00 by HC Wainwright & Co.
Dow Jones·03/23 11:18
Repligen Is Maintained at Buy by HC Wainwright & Co.
Benzinga·03/23 11:08
HC Wainwright & Co. Maintains Buy on Repligen, Raises Price Target to $208
TipRanks·03/23 10:11
Repligen price target raised to $208 from $180 at H.C. Wainwright
Same Industry
Name/Symbol
Change%
Price